Bio Preventive Medicine Corp., being one of the top innovative clinical-staged biotech company will attend BIO Asia–Taiwan 2024 from July 25th to 28th at TaiNEX 1, 4F. It is an endorsement of BPM's standing as a leading biotech company in renal biomarker industry. Come meeting us and learn more about DNlite-IVD103, the world premier evolution for precise diagnosis and prognosis of kidney disease progression.
Pin your calendar and visit our booth at N406. For more information, please visit: https://bioasiataiwan.com/en
.png)
Our CEO Dr. Karen Tseng and VP Jennifer Tseng will give a speech on July 26th and 28th. We welcome everyone to join us and know more about DNlite-IVD103.